Cited by 841Lipoproteins and Cardiovascular HealthHealth Promotion and Cardiovascular PreventionCardiovascular Health and Risk Factors

The DOI matches its Crossref record, with a small difference in title or year; 27 of the 27 references it cites were found in a registry or an index.

C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men

Open access

Ridker, Paul M, Paynter, Nina P., Rifai, Nader, Gaziano, J. Michael, Cook, Nancy R.·2008·Circulation

DOI 10.1161/circulationaha.108.814251PMC PMC2752381

Open this paper in CoChat — free account Open PDF

Abstract

Background— High-sensitivity C-reactive protein and family history are independently associated with future cardiovascular events and have been incorporated into risk prediction models for women (the Reynolds Risk Score for women); however, no cardiovascular risk prediction algorithm incorporating these variables currently exists for men. Methods and Results— Among 10 724 initially healthy American nondiabetic men who were followed up prospectively over a median period of 10.8 years, we compared the test characteristics of global model fit, discrimination, calibration, and reclassification in 2 prediction models for incident cardiovascular events, one based on age, blood pressure, smoking status, total cholesterol, and high-density lipoprotein cholesterol (traditional model) and the other based on these risk factors plus high-sensitivity C-reactive protein and parental history of myocardial infarction before age 60 years (Reynolds Risk Score for men). A total of 1294 cardiovascular events accrued during study follow-up. Compared with the traditional model, the Reynolds Risk Score had better global fit (likelihood ratio test P <0.001), a superior (lower) Bayes information criterion, and a larger C-index ( P <0.001). For the end point of all cardiovascular events, the Reynolds Risk Score for men reclassified 17.8% (1904/10 724) of the study population (and 20.2% [1392/6884] of those at 5% to 20% 10-year risk) into higher- or lower-risk categories, with markedly improved accuracy among those reclassified. For this model comparison, the net reclassification index was 5.3%, and the clinical net reclassification index was 14.2% (both P <0.001). In models based on the Adult Treatment Panel III preferred end point of coronary heart disease and limited to men not taking lipid-lowering therapy, 16.7% of the study population (and 20.1% of those at 5% to 20% 10-year risk) were reclassified to higher- or lower-risk groups, again with significantly improved global fit, larger C-index ( P <0.001), and markedly improved accuracy among those reclassified. For this model, the net reclassification index was 8.4% and the clinical net reclassification index was 15.8% (both P <0.001). Conclusions— As previously shown in women, a prediction model in men that incorporates high-sensitivity C-reactive protein and parental history significantly improves global cardiovascular risk prediction.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/circulationaha.108.814251

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Regression Modeling Strategies
Harrell, F. E. (2001) · Springer series in statistics · doi:10.1007/978-1-4757-3462-1 · Cited by 9,270
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
Regression Modeling Strategies: With Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis
Harrell (2015) · Springer Series in Statistics · doi:10.1007/978-3-319-19425-7 · Cited by 6,878
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction
Cook, N. R. (2007) · Circulation · doi:10.1161/circulationaha.106.672402 · Cited by 2,156
Self-citation
Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women: The Reynolds Risk Score
Ridker, P. M., Buring, J. E., Rifai, N., & Cook, N. R. (2007) · JAMA · doi:10.1001/jama.297.6.611 · Cited by 1,814
Self-citation

Show all 27 references

Research works printed but not linked: 2

10.1161/circ.86.5.1330360 · DOI
10.1161/hyp.39.1.105 · DOI

Sorted by citations

Items 201–300 of 840

Predicting the risk of coronary heart disease
Dent, T. H. S. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.06.019 · Cited by 57
Relationship of CRP, IL-6, and fibrinogen with right ventricular structure and function: The MESA-Right Ventricle Study
Harhay, M. O., Tracy, R. P., Bagiella, E., Barr, R. G., Pinder, D., Hundley, W. G., Bluemke, D. A., Kronmal, R. A., Lima, J. A. C., & Kawut, S. M. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.06.028 · Cited by 55
Model for Assessing Cardiovascular Risk in a Korean Population
Park, G.-M., Han, S., Kim, S., Jo, M., Her, S., Lee, J. B., Lee, M.-S., Kim, H. C., Ahn, J., Lee, S., et al. (2014) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.114.001305 · Cited by 57
Risk Prediction for Early In-Hospital Mortality Following Heart Transplantation in the United States
Singh, T. P., Almond, C. S. D., Semigran, M. J., Piercey, G. E., & Gauvreau, K. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.111.965996 · Cited by 56
The Terneuzen Birth Cohort: BMI Change between 2 and 6 Years Is Most Predictive of Adult Cardiometabolic Risk
de Kroon, M. L. A., Renders, C. M., Wouwe, J. P. V., van Buuren, S., & Hirasing, R. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013966 · Cited by 55
Lipid profile and effect of statin treatment in pooled phase II and phase III baricitinib studies
Taylor, P., Kremer, J., Emery, P., Zuckerman, S., Ruotolo, G., Zhong, J., Chen, L., Witt, S., Saifan, C., Kurzawa, M., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-212461 · Cited by 57
Prevalence of Low Low-Density Lipoprotein Cholesterol With Elevated High Sensitivity C-Reactive Protein in the U.S.
Michos, E. D., & Blumenthal, R. S. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.010 · Cited by 55
Diagnosis and Treatment of Erectile Dysfunction for Reduction of Cardiovascular Risk
Nehra, A. X., Jackson, G., Miner, M. M., Billups, K. L., Burnett, A. L. “., Buvat, J., Carson, C. C., Cunningham, G. R., Goldstein, I., Guay, A. T., et al. (2013) · The Journal of Urology · doi:10.1016/j.juro.2012.12.107 · Cited by 54
Adipose tissue and vascular inflammation in coronary artery disease
Golia, E. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i7.539 · Cited by 56
Unrequested information from routine diagnostic chest CT predicts future cardiovascular events
Jacobs, P. C. A., Gondrie, M. J. A., Mali, W. P. T. M., Oen, A. L., Prokop, M., Grobbee, D. E., & van der Graaf, Y. (2011) · European Radiology · doi:10.1007/s00330-011-2112-8 · Cited by 52
The art of cardiovascular risk assessment
Khambhati, J., Allard‐Ratick, M., Dhindsa, D. S., Lee, S. K., Chen, J. L., Sandesara, P. B., O’Neal, W. T., Quyyumi, A. A., Wong, N. D., Blumenthal, R. S., et al. (2018) · Clinical Cardiology · doi:10.1002/clc.22930 · Cited by 51
CVD screening in low-risk, asymptomatic adults: clinical trials needed
Polonsky, T. S., & Greenland, P. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.114 · Cited by 50
Importance of Biomarkers for Long-Term Mortality Prediction in Acutely Dyspneic Patients
Januzzi, J. L., Rehman, S., Mueller, T., van Kimmenade, R. R. J., & Lloyd‐Jones, D. M. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.146506 · Cited by 51
Fasting and OGTT-derived Measures of Insulin Resistance as Compared With the Euglycemic-Hyperinsulinemic Clamp in Nondiabetic Finnish Offspring of Type 2 Diabetic Individuals
Lorenzo, C., Haffner, S. M., Stančáková, A., Kuusisto, J., & Laakso, M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2299 · Cited by 50
Efficacy of a family-based cardiovascular risk reduction intervention in individuals with a family history of premature coronary heart disease in India (PROLIFIC): an open-label, single-centre, cluster randomised controlled trial
Jeemon, P., Harikrishnan, S., Ganapathi, S., Sivasankaran, S., Bhaskarapillai, B., Padmanabhan, S., Tandon, N., & Prabhakaran, D. (2021) · The Lancet Global Health · doi:10.1016/s2214-109x(21)00319-3 · Cited by 48
Obesity-related inflammation & cardiovascular disease: efficacy of a yoga-based lifestyle intervention.
Sarvottam, K., & Yadav, R. K. (2014) · Europe PMC (PubMed Central) · Cited by 51
Coronary Artery Calcium Screening: Does it Perform Better than Other Cardiovascular Risk Stratification Tools?
Zeb, I., & Budoff, M. J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16036606 · Cited by 49
Integrating Information From Novel Risk Factors With Calculated Risks
Kooter, A. J., Kostense, P. J., Groenewold, J., Thijs, A., Sattar, N. A., & Smulders, Y. M. (2011) · Circulation · doi:10.1161/circulationaha.111.035725 · Cited by 49
Should we expand the concept of coronary heart disease equivalents?
Katsiki, N., Athyros, V. G., Karagiannis, A. I., Wierzbicki, A. S., & Mikhailidis, D. P. (2014) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000068 · Cited by 49
Prevention of atherosclerotic cardiovascular disease in South Asians in the US: A clinical perspective from the National Lipid Association
Kalra, D. K., Vijayaraghavan, K., Sikand, G., Desai, N. R., Joshi, P. H., Mehta, A., Karmally, W., Vani, A. K., Sitafalwalla, S. J., Puri, R., et al. (2021) · Journal of clinical lipidology · doi:10.1016/j.jacl.2021.03.007 · Cited by 50
PPBP and DEFA1/DEFA3 genes in hyperlipidaemia as feasible synergistic inflammatory biomarkers for coronary heart disease
Maneerat, Y., Prasongsukarn, K., Benjathummarak, S., & Dechkhajorn, W. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0471-0 · Cited by 48
Sedentary lifestyle and Framingham risk scores: a population-based study in Riyadh city, Saudi Arabia
Alquaiz, A. M., Siddiqui, A. R., Kazi, A., Batais, M. A., & Al-Hazmi, A. (2019) · BMC Cardiovascular Disorders · doi:10.1186/s12872-019-1048-9 · Cited by 52
2019 AHA/ACC Clinical Performance and Quality Measures for Adults With High Blood Pressure
Casey, D. E., Thomas, R. J., Bhalla, V., Commodore-Mensah, Y. Y., Heidenreich, P. A., Kolte, D. S., Muntner, P., Smith, S. C., Spertus, J. A., Windle, J. R., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.10.001 · Cited by 48
Prediction of Cardiovascular Events in Statin-Treated Stable Coronary Patients of the Treating to New Targets Randomized Controlled Trial by Lipid and Non-Lipid Biomarkers
Arsenault, B. J., Barter, P. J., DeMicco, D. A., Bao, W., Preston, G. M., LaRosa, J. C., Grundy, S. M., DEEDWANIA, P. C., Greten, H., WENGER, N. K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114519 · Cited by 48
High-Sensitive C-Reactive Protein: Universal Prognostic and Causative Biomarker in Heart Disease?
Rietzschel, E. R., & Buyzere, M. D. (2012) · Biomarkers in Medicine · doi:10.2217/bmm.11.108 · Cited by 49
Cardiovascular Disease: Prediction with Ancillary Aortic Findings on Chest CT Scans in Routine Practice
Gondrie, M. J. A., Mali, W. P. T. M., Jacobs, P. C. A., Oen, A. L., van der Graaf, Y., & For the PROVIDI Study Group (2010) · Radiology · doi:10.1148/radiol.10100054 · Cited by 46
An innovative model for predicting coronary heart disease using triglyceride-glucose index: a machine learning-based cohort study
Mirjalili, S. R., Soltani, S., Meybodi, Z. H., Marques-Vidal, P. M., Kraemer, A., & Sarebanhassanabadi, M. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01939-9 · Cited by 50
Factores de riesgo cardiovascular y atención primaria: evaluación e intervención
Bejarano, J. M. L., & Cuixart, C. B. (2011) · Atención Primaria · doi:10.1016/j.aprim.2011.10.002 · Cited by 46
Development of an intelligent decision support system for ischemic stroke risk assessment in a population-based electronic health record database
Hung, C.-Y., Lin, C., Lan, T., Peng, G.-S., & Lee, C.-C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213007 · Cited by 44
Risk stratification in cardiovascular disease primary prevention – scoring systems, novel markers, and imaging techniques
Zannad, F. M., Backer, G. D., Graham, I. M., Lorenz, M., Mancia, G., Morrow, D. A., Reiner, Ž., Köenig, W., Dallongeville, J., MacFadyen, R. J., et al. (2012) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2011.01023.x · Cited by 47
CCTA in the diagnosis of coronary artery disease
Marano, R., Rovere, G., Savino, G., Flammia, F. C., Carafa, M. R. P., Steri, L., Merlino, B., & Natale, L. (2020) · La radiologia medica · doi:10.1007/s11547-020-01283-y · Cited by 46
C-Reactive Protein and Colorectal Cancer Mortality in U.S. Adults
Goyal, A., Terry, M. B., Jin, Z., & Siegel, A. B. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0577 · Cited by 45
Glycated Apolipoprotein A-IV Induces Atherogenesis in Patients With CAD in Type 2 Diabetes
Dai, Y., Shen, Y. H., Li, Q., Ding, F. H., Wang, X. Q., Liu, H. J., Yan, X. X., Wang, L. J., Yang, K., Wang, H. B., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.08.053 · Cited by 46
Circulating microRNAs as predictive biomarkers of myocardial infarction: Evidence from the HUNT study
Velle-Forbord, T., Eidlaug, M., Debik, J., Sæther, J. C., Follestad, T., Nauman, J., Gigante, B., Røsjø, H. R., Omland, T., Langaas, M., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.07.024 · Cited by 46
Explainable machine learning framework for predicting long-term cardiovascular disease risk among adolescents
Salah, H., & Srinivas, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-25933-5 · Cited by 48
Jeremiah Metzger Lecture: cholesterol, inflammation and atherosclerotic cardiovascular disease: is it all LDL?
Gotto, A. M. (2011) · PubMed Central · Cited by 44
Paternal or maternal history of cardiovascular disease and the risk of cardiovascular disease in offspring. A systematic review and meta-analysis
Weijmans, M., van der Graaf, Y., Reitsma, J. B., & Visseren, F. L. J. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.11.017 · Cited by 48
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study
Navarini, L., Margiotta, D. P. E., Caso, F., Currado, D., Tasso, M., Angeletti, S., Ciccozzi, M., Scarpa, R., Afeltra, A., & Costa, L. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205506 · Cited by 44
Integrated brain restoration after ischemic stroke--medical management, risk factors, nutrients, and other interventions for managing inflammation and enhancing brain plasticity.
Kidd, P. M. (2009) · PubMed · Cited by 44
Early identification of atherosclerotic disease by noninvasive imaging
Fuster, V., Lois, F., & Franco, M. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.54 · Cited by 46
Aspirin for Primary Prevention of Cardiovascular Disease Events
Nemerovski, C. W., Salinitri, F. D., Morbitzer, K. A., & Moser, L. R. (2012) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1127 · Cited by 43
Journey in guidelines for lipid management: From adult treatment panel (ATP)-I to ATP-III and what to expect in ATP-IV
Gulati, A., Talwalkar, P., Sreenivas, C., & Baxi, H. A. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.113753 · Cited by 42
Inflammatory cytokines as predictive markers for early detection and progression of diabetic nephropathy
Elmarakby, A. A., Abdelsayed, R. A., Liu, J. Y., & Mozaffari, M. S. (2010) · The EPMA Journal · doi:10.1007/s13167-010-0004-7 · Cited by 43
Design, Operation, and Interpretation of Clinical Trials
Pihlstrom, B. L., & Barnett, M. L. (2010) · Journal of Dental Research · doi:10.1177/0022034510374737 · Cited by 43
Prediction and classification of cardiovascular disease risk in older adults with diabetes
Mukamal, K. J., Kizer, J. R., Djoussé, L., Ix, J. H., Zieman, S. J., Siscovick, D. S., Sibley, C. T., Tracy, R. P., & Arnold, A. M. (2012) · Diabetologia · doi:10.1007/s00125-012-2772-1 · Cited by 39
Investigation on Cardiovascular Risk Prediction Using Physiological Parameters
Lin, W.-H., Zhang, H., & Zhang, Y. (2013) · Computational and Mathematical Methods in Medicine · doi:10.1155/2013/272691 · Cited by 42
Effect of carotid image-based phenotypes on cardiovascular risk calculator: AECRS1.0
Khanna, N. N., Jamthikar, A. D., Gupta, D., Araki, T., Piga, M., Saba, L., Carcassi, C., Nicolaides, A. N., Laird, J. R., Suri, H. S., et al. (2019) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-019-01975-2 · Cited by 42
Plasma lipidomic analysis predicts non-calcified coronary artery plaque in asymptomatic patients at intermediate risk of coronary artery disease
Ellims, A. H., Wong, G., Weir, J. M., Lew, P., Meikle, P. J., & Taylor, A. J. (2014) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeu033 · Cited by 41
General Cardiovascular Risk Profile Identifies Advanced Coronary Artery Calcium and Is Improved by Family History
Scheuner, M. T., Setodji, C. M., Pankow, J. S., Blumenthal, R. S., & Keeler, E. B. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.109.894527 · Cited by 40
A diet based on multiple functional concepts improves cognitive performance in healthy subjects
Nilsson, A. C., Tovar, J., Johansson, M., Radeborg, K., & Björck, I. (2013) · Nutrition & Metabolism · doi:10.1186/1743-7075-10-49 · Cited by 41
The influence of low-grade inflammation on platelets in patients with stable coronary artery disease
Larsen, S. B., Grove, E. L., Würtz, M., Neergaard‐Petersen, S., Hvas, A., & Kristensen, S. D. (2015) · Thrombosis and Haemostasis · doi:10.1160/th14-12-1007 · Cited by 39
Cardiovascular risk prediction: Can Systematic Coronary Risk Evaluation (SCORE) be improved by adding simple risk markers? Results from the Copenhagen City Heart Study
Graversen, P. L., Abildstrom, S. Z., Jespersen, L., Borglykke, A., & Prescott, E. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316638201 · Cited by 41
A new non-invasive diagnostic tool in coronary artery disease: artificial intelligence as an essential element of predictive, preventive, and personalized medicine
Zellweger, M. J., Tsirkin, A., Vasilchenko, V., Failer, M., Dressel, A., Kleber, M. E., Ruff, P., & März, W. (2018) · The EPMA Journal · doi:10.1007/s13167-018-0142-x · Cited by 41
Ranking of stroke and cardiovascular risk factors for an optimal risk calculator design: Logistic regression approach
Cuadrado‐Godia, E., Jamthikar, A. D., Gupta, D., Khanna, N. N., Araki, T., Maniruzzaman, M., Saba, L., Nicolaides, A. N., Sharma, A., Omerzu, T., et al. (2019) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2019.03.020 · Cited by 41
Machine learning based risk prediction model for asymptomatic individuals who underwent coronary artery calcium score: Comparison with traditional risk prediction approaches
Han, D., Kolli, K. K., Gransar, H., Lee, J. H., Choi, S.-Y., Chun, E. J., Han, H.-W., Park, S. H., Sung, J., Jung, H. O., et al. (2020) · Journal of Cardiovascular Computed Tomography · doi:10.1016/j.jcct.2019.09.005 · Cited by 41
Subclinical Atherosclerosis: Evolving Role of Carotid Intima-Media Thickness
Mookadam, F., Moustafa, S., Lester, S. J., & Warsame, T. A. (2010) · Preventive Cardiology · doi:10.1111/j.1751-7141.2010.00072.x · Cited by 40
Adverse pregnancy conditions, infertility, and future cardiovascular risk: implications for mother and child
Park, K., Wei, J., Minissian, M., Bairey Merz, C. N., & Pepine, C. J. (2015) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-015-6597-2 · Cited by 40
Cardiovascular risk biomarkers in CKD: the inflammation link and the road less traveled
Elewa, U., Sánchez-Niño, M. D., Martín-Cleary, C., Fernández‐Fernández, B., Egido, J., & Ortíz, A. (2012) · International Urology and Nephrology · doi:10.1007/s11255-012-0271-4 · Cited by 43
Cardiovascular Disease Risk Factor Patterns and Their Implications for Intervention Strategies in Vietnam
Nguyen, Q. N., Pham, S. T., Do, D. L., Nguyen, V. L., Wall, S., Weinehall, L., Bonita, R., & Byass, P. (2012) · International Journal of Hypertension · doi:10.1155/2012/560397 · Cited by 40
High-density lipoproteins and cardiovascular disease: 2010 update
Al-Waili, K., Awan, Z. A., Alshahrani, A., & Genest, J. J. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.4 · Cited by 39
Association Between High-Sensitivity C-Reactive Protein and Coronary Plaque Subtypes Assessed by 64-Slice Coronary Computed Tomography Angiography in an Asymptomatic Population
Rubin, J., Chang, H., Nasir, K., Blumenthal, R. S., Blaha, M. J., Choi, E., Chang, S., Yoon, Y. E., Chun, E. J., Choi, S., et al. (2011) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.109.929901 · Cited by 40
Underestimation of Risk of Carotid Subclinical Atherosclerosis by Cardiovascular Risk Scores in Patients with Psoriatic Arthritis
Shen, J., Lam, S. H. M., Shang, Q., Wong, C. K., Li, E. K., Wong, P. C. H., Kun, E. W. L., Cheng, I. T., Li, M., Li, T. K., et al. (2017) · The Journal of Rheumatology · doi:10.3899/jrheum.170025 · Cited by 39
Understanding and managing cardiovascular outcomes in liver transplant recipients
Izzy, M. J., VanWagner, L. B., Lee, S. S., Altieri, M. H., Angirekula, M., & Watt, K. D. S. (2019) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000614 · Cited by 41
Assessing the incremental role of novel and emerging risk factors.
Cook, N. R. (2010) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-010-0084-x · Cited by 39
Self-citation
Which markers of subclinical organ damage to measure in individuals with high normal blood pressure?
Sehestedt, T. B., Jeppesen, J., Hansen, T. W., Rasmussen, S. L., Wachtell, K., Ibsen, H., Torp-Pedersen, C. T., & Olsen, M. H. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832af343 · Cited by 39
Disease Activity in Ankylosing Spondylitis and Associations to Markers of Vascular Pathology and Traditional Cardiovascular Disease Risk Factors: A Cross-sectional Study
Berg, I. J., van der Heijde, D. M. F. M., Dagfinrud, H. S., Seljeflot, I., Olsen, I. C., Kvien, T. K., Semb, A. G., & Provan, S. A. (2015) · The Journal of Rheumatology · doi:10.3899/jrheum.141018 · Cited by 39
Ischemic Heart Disease and Rheumatoid Arthritis—Two Conditions, the Same Background
Rezuş, E., Macovei, L. A., Burlui, A., Cardoneanu, A., & Rezuș, C. (2021) · Life · doi:10.3390/life11101042 · Cited by 41
Agreement Between Cardiovascular Disease Risk Scores in Resource-Limited Settings
Bazo‐Alvarez, J. C., Quispe, R., Peralta, F. B. B., Poterico, J. A., Valle, G. A., Peña, M. S. B., Pillay, T. D., Gilman, R. H., Checkley, W., Málaga, G., et al. (2015) · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine · doi:10.1097/hpc.0000000000000045 · Cited by 39
Methods for evaluating novel biomarkers - a new paradigm
Cook, N. R. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02469.x · Cited by 39
Self-citation
Cardiac ScoreCard: A diagnostic multivariate index assay system for predicting a spectrum of cardiovascular disease
McRae, M. P., Bozkurt, B., Ballantyne, C. M., Sanchez, X., Christodoulides, N. J., Simmons, G. W., Nambi, V., Misra, A., Miller, C. S., Ebersole, J. L., et al. (2016) · Expert Systems with Applications · doi:10.1016/j.eswa.2016.01.029 · Cited by 38
Coronary risk assessment among intermediate risk patients using a clinical and biomarker based algorithm developed and validated in two population cohorts
Cross, D. S., McCarty, C. A., Hytopoulos, E., Beggs, M., Nolan, N., Harrington, D. S., Hastie, T. J., Tibshirani, R. J., Tracy, R. P., Psaty, B. M., et al. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.742878 · Cited by 39
A diet based on multiple functional concepts improves cardiometabolic risk parameters in healthy subjects
Tovar, J., Nilsson, A. C., Johansson, M., Ekesbo, R. W., Aberg, A.-M., Johansson, U., & Björck, I. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-29 · Cited by 39
Cardiovascular disease risk in patients with hepatitis C infection: Results from two general population health surveys in Canada and the United States (2007-2017)
Badawi, A. F., Giuseppe, G. D., & Arora, P. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208839 · Cited by 37
Women and Cardiovascular Disease: Pregnancy, the Forgotten Risk Factor
Arnott, C. G., Patel, S., Hyett, J. A., Jennings, G., Woodward, M., & Celermajer, D. S. (2019) · Heart Lung and Circulation · doi:10.1016/j.hlc.2019.09.011 · Cited by 37
Integration of cardiovascular risk assessment with COVID-19 using artificial intelligence
Suri, J. S., Puvvula, A., Majhail, M., Biswas, M., Jamthikar, A. D., Saba, L., Faa, G., Singh, I. M., Oberleitner, R., Turk, M., et al. (2020) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm.2020.04.236 · Cited by 37
Noninvasive Detection of Vulnerable Coronary Plaques
D, E. B. M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.03.040 · Cited by 37
Unmet Needs for Cardiovascular Care in Indonesia
Maharani, A., & Tampubolon, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105831 · Cited by 36
RETRACTED: Prediction of Cardiovascular Events in Statin-Treated Stable Coronary Patients by Lipid and Nonlipid Biomarkers
Arsenault, B. J., Barter, P. J., DeMicco, D. A., Bao, W., Preston, G. M., LaRosa, J. C., Grundy, S. M., DEEDWANIA, P. C., Greten, H., WENGER, N. K., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.052 · Cited by 36
Retracted
Big-Data Based Decision-Support Systems to Improve Clinicians' Cognition
Roosan, D., Samore, M. H., Jones, M., Livnat, Y., & Clutter, J. (2016) · IEEE International Conference on Healthcare Informatics (ICHI) · doi:10.1109/ichi.2016.39 · Cited by 36
Cardiovascular Risk Assessment
Pletcher, M. J., & Moran, A. E. (2017) · Medical Clinics of North America · doi:10.1016/j.mcna.2017.03.002 · Cited by 42
Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib—Implications for Cardiovascular Risk and Patient Management
Sands, B. E., Colombel, J., Ha, C. Y., Farnier, M., Armuzzi, A., Quirk, D., Friedman, G. S., Kwok, K., Salese, L., Su, C. G., et al. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa227 · Cited by 36
Creatinine versus cystatin C for renal function-based mortality prediction in an elderly cohort: The Northern Manhattan Study
Willey, J. Z., Moon, Y. P., Husain, S. A., Elkind, M. S. V., Sacco, R. L., Wolf, M. S., Cheung, K., Wright, C. B., & Mohan, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0226509 · Cited by 38
Validación de los modelos de predicción de Framingham y PROCAM como estimadores del riesgo cardiovascular en una población colombiana
Múñoz, Ó., Rodriguez, N. I., Ruiz, Á. J., & Rondón, M. (2014) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2014.02.001 · Cited by 37
Metabolic Syndrome Prevalence in Psoriasis
Parodi, A., Aste, N., Calvieri, C., Cantoresi, F., Carlesimo, M., Fabbri, P., Filosa, G., Galluccio, A. G., Lisi, P., Micali, G., et al. (2014) · American Journal of Clinical Dermatology · doi:10.1007/s40257-014-0074-8 · Cited by 35
Total cholesterol-to-high-density lipoprotein cholesterol ratio predicts high-sensitivity C-reactive protein levels in Turkish children
Ağırbaşlı, M. A., Tanrikulu, A. M., Sevim, B. A., Azizy, A., & Bekiroğlu, N. (2014) · Journal of clinical lipidology · doi:10.1016/j.jacl.2014.12.010 · Cited by 33
Incremental value of a genetic risk score for the prediction of new vascular events in patients with clinically manifest vascular disease
Weijmans, M., de Bakker, P. I. W., van der Graaf, Y., Asselbergs, F. W., Algra, A., de Borst, G. J., Spiering, W., & Visseren, F. L. J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.02.008 · Cited by 33
The 2013 ACC/AHA 10-year atherosclerotic cardiovascular disease risk index is better than SCORE and QRisk II in rheumatoid arthritis: is it enough?
Özen, G., Sünbül, M., Atagündüz, P., Di̇reskeneli̇, H., Tigen, K., & İnanç, N. (2015) · Lara D. Veeken · doi:10.1093/rheumatology/kev363 · Cited by 34
Primary and Secondary Prevention of Coronary Heart Disease
Gaziano, J. M., Ridker, P. M., & Libby, P. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0398-6.00049-4 · Cited by 34
Self-citation
Cardiometabolic risk prediction algorithms for young people with psychosis: a systematic review and exploratory analysis
Perry, B. I., Upthegrove, R., Crawford, O., Jang, S.-H., Lau, E., McGill, I., Carver, E., Jones, P. B., & Khandaker, G. M. (2020) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13212 · Cited by 36
Predictive Value of Updating Framingham Risk Scores with Novel Risk Markers in the U.S. General Population
Ferket, B. S., van Kempen, B. J. H., Hunink, M. G. M., Agarwal, I., Kavousi, M., Franco, O. H., Steyerberg, E. W., Max, W. B., & Fleischmann, K. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088312 · Cited by 37
Physical activity, the Framingham risk score and risk of coronary heart disease in men and women of the EPIC-Norfolk study
Arsenault, B. J., Rana, J. S., Lemieux, I., Després, J., Wareham, N. J., Kastelein, J. J. P., Boekholdt, S. M., & Khaw, K. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.08.048 · Cited by 34
Use of Obesity Biomarkers in Cardiovascular Epidemiology
Pischon, T. (2009) · Disease Markers · doi:10.1155/2009/757683 · Cited by 34
Cardiovascular Risk Factors in the Elderly
Melek, Z. (2012) · InTech eBooks · doi:10.5772/32362 · Cited by 34
Cardiovascular risk in rheumatoid arthritis and diabetes: how does it compare and when does it start?
Nurmohamed, M. T., & Kitas, G. D. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.145839 · Cited by 34
Landmark Lipid‐Lowering Trials in the Primary Prevention of Cardiovascular Disease
Chrispin, J., Martin, S. S., Hasan, R. K., Joshi, P. H., Minder, C. M., McEvoy, J. W., Kohli, P., Johnson, A. E., Wang, L., Blaha, M. J., et al. (2013) · Clinical Cardiology · doi:10.1002/clc.22147 · Cited by 36
Reduced serum levels of vasostatin-2, an anti-inflammatory peptide derived from chromogranin A, are associated with the presence and severity of coronary artery disease
Lu, L., Wang, Y. N., Li, M. C., Wang, H. B., Pu, L. J., Niu, W. Q., Meng, H., Yang, E. L., Zhang, R., Zhang, Q., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs122 · Cited by 33
Plasma 7-ketocholesterol levels and the risk of incident cardiovascular events
Wang, M., Long, W., Li, D., Wang, D., Yuan, Ž., Mu, D., Song, J., & Xia, M. (2017) · Heart · doi:10.1136/heartjnl-2016-310914 · Cited by 33
A Life Course Approach to Cardiovascular Disease Prevention
Hayman, L. L., Helden, L., Chyun, D. A., & Braun, L. T. (2011) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e318213ef7f · Cited by 34
Cardiovascular Disease Risk Modeling for Astronauts: Making the Leap From Earth to Space
Huff, J. L., Plante, I., Blattnig, S. R., Norman, R. B., Little, M. P., Khera, A., Simonsen, L. C., & Patel, Z. S. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.873597 · Cited by 34
A multifunctional diet improves cardiometabolic-related biomarkers independently of weight changes: an 8-week randomized controlled intervention in healthy overweight and obese subjects
Tovar, J., Johansson, M., & Björck, I. (2015) · European Journal of Nutrition · doi:10.1007/s00394-015-1039-2 · Cited by 33

Authors: Ridker, P. M., Paynter, N. P., Rifai, N., Gaziano, J. M., & Cook, N. R.
Affiliations: Brigham and Women's Hospital (US)
ORCID: Ridker, Paul M
Paynter, Nina P.
Rifai, Nader
Gaziano, J. Michael
Cook, Nancy R.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2008-11-25
Volume: 118
Issue: 22
Pages: 2243-2251
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/circulationaha.108.814251
PMC: PMC2752381
OpenAlex: W2096807144
Semantic Scholar: 4e13b2445d617740f45915eafd75712fdf825998
Cited by: 841
References: 27
Citations by year: 2026: 11 · 2025: 22 · 2024: 20 · 2023: 25 · 2022: 23 · 2021: 32 · 2020: 31 · 2019: 39 · 2018: 42 · 2017: 37 · 2016: 47 · 2015: 68 · 2014: 63 · 2013: 53 · 2012: 92
FWCI: 80.90
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Cancer Institute (R01CA097193)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
Keywords: Reynolds Risk Score, cardiovascular risk prediction, men, family history of myocardial infarction, coronary artery disease, risk reclassification, net reclassification improvement, coronary risk factors, hypertriglyceridemia, hypercholesterolemia, LDL cholesterol, HDL cholesterol, blood pressure, smoking, non-diabetic men
MeSH terms: C-Reactive Protein, Cardiovascular Diseases, Female, Follow-Up Studies, Humans, Inflammation, Life Style, Male, Predictive Value of Tests, Prospective Studies, Sex Characteristics, Biomarkers, Likelihood Functions, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks